Intervention to enhance communication about newly prescribed medications

Derjung M. Tarn, Debora A Paterniti, Deborah K. Orosz, Chi Hong Tseng, Neil S. Wenger

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

PURPOSE Physicians prescribing new medications often do not convey important medication-related information. This study tests an intervention to improve physician-patient communication about newly prescribed medications. METHODS We conducted a controlled clinical trial of patients in 3 primary care practices, combining data from patient surveys with audio-recorded physician-patient interactions. The intervention consisted of a 1-hour physician-targeted interactive educational session encouraging communication about 5 basic elements regarding a new prescription and a patient information handout listing the 5 basic elements. Main outcome measures were the Medication Communication Index (MCI), a 5-point index assessed by qualitative analysis of audio-recorded interactions (giving points for discussion of medication name, purpose, directions for use, duration of use, and side effects), and patient ratings of physician communication about new prescriptions. RESULTS Twenty-seven physicians prescribed 113 new medications to 82 of 256 patients. The mean MCI for medications prescribed by physicians in the intervention group was 3.95 (SD = 1.02), signif cantly higher than that for medications prescribed by control group physicians (2.86, SD = 1.23, P < 001). This effect held regardless of medication type (chronic vs nonchronic medication). Counseling about 3 of the 5 MCI components was signif cantly higher for medications prescribed by physicians in the intervention group, as were patients' ratings of new medication information transfer (P = 02). Independent of intervention or control groups, higher MCI scores were associated with better patient ratings about information about new prescriptions (P = 003). CONCLUSIONS A physician-targeted educational session improved the content of and enhanced patient ratings of physician communication about new medication prescriptions. Further work is required to assess whether improved communication stimulated by the intervention translates into better clinical outcomes.

Original languageEnglish (US)
Pages (from-to)28-36
Number of pages9
JournalAnnals of Family Medicine
Volume11
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Communication
Physicians
Prescriptions
Control Groups
Controlled Clinical Trials
Names
Counseling
Primary Health Care
Outcome Assessment (Health Care)

Keywords

  • Communication
  • Intervention studies
  • Physician-patient relations
  • Prescriptions

ASJC Scopus subject areas

  • Family Practice

Cite this

Intervention to enhance communication about newly prescribed medications. / Tarn, Derjung M.; Paterniti, Debora A; Orosz, Deborah K.; Tseng, Chi Hong; Wenger, Neil S.

In: Annals of Family Medicine, Vol. 11, No. 1, 01.2013, p. 28-36.

Research output: Contribution to journalArticle

Tarn, Derjung M. ; Paterniti, Debora A ; Orosz, Deborah K. ; Tseng, Chi Hong ; Wenger, Neil S. / Intervention to enhance communication about newly prescribed medications. In: Annals of Family Medicine. 2013 ; Vol. 11, No. 1. pp. 28-36.
@article{8e149e094d324565add0f61f4b65d14f,
title = "Intervention to enhance communication about newly prescribed medications",
abstract = "PURPOSE Physicians prescribing new medications often do not convey important medication-related information. This study tests an intervention to improve physician-patient communication about newly prescribed medications. METHODS We conducted a controlled clinical trial of patients in 3 primary care practices, combining data from patient surveys with audio-recorded physician-patient interactions. The intervention consisted of a 1-hour physician-targeted interactive educational session encouraging communication about 5 basic elements regarding a new prescription and a patient information handout listing the 5 basic elements. Main outcome measures were the Medication Communication Index (MCI), a 5-point index assessed by qualitative analysis of audio-recorded interactions (giving points for discussion of medication name, purpose, directions for use, duration of use, and side effects), and patient ratings of physician communication about new prescriptions. RESULTS Twenty-seven physicians prescribed 113 new medications to 82 of 256 patients. The mean MCI for medications prescribed by physicians in the intervention group was 3.95 (SD = 1.02), signif cantly higher than that for medications prescribed by control group physicians (2.86, SD = 1.23, P < 001). This effect held regardless of medication type (chronic vs nonchronic medication). Counseling about 3 of the 5 MCI components was signif cantly higher for medications prescribed by physicians in the intervention group, as were patients' ratings of new medication information transfer (P = 02). Independent of intervention or control groups, higher MCI scores were associated with better patient ratings about information about new prescriptions (P = 003). CONCLUSIONS A physician-targeted educational session improved the content of and enhanced patient ratings of physician communication about new medication prescriptions. Further work is required to assess whether improved communication stimulated by the intervention translates into better clinical outcomes.",
keywords = "Communication, Intervention studies, Physician-patient relations, Prescriptions",
author = "Tarn, {Derjung M.} and Paterniti, {Debora A} and Orosz, {Deborah K.} and Tseng, {Chi Hong} and Wenger, {Neil S.}",
year = "2013",
month = "1",
doi = "10.1370/afm.1417",
language = "English (US)",
volume = "11",
pages = "28--36",
journal = "Annals of Family Medicine",
issn = "1544-1709",
publisher = "Annals of Family Medicine, Inc",
number = "1",

}

TY - JOUR

T1 - Intervention to enhance communication about newly prescribed medications

AU - Tarn, Derjung M.

AU - Paterniti, Debora A

AU - Orosz, Deborah K.

AU - Tseng, Chi Hong

AU - Wenger, Neil S.

PY - 2013/1

Y1 - 2013/1

N2 - PURPOSE Physicians prescribing new medications often do not convey important medication-related information. This study tests an intervention to improve physician-patient communication about newly prescribed medications. METHODS We conducted a controlled clinical trial of patients in 3 primary care practices, combining data from patient surveys with audio-recorded physician-patient interactions. The intervention consisted of a 1-hour physician-targeted interactive educational session encouraging communication about 5 basic elements regarding a new prescription and a patient information handout listing the 5 basic elements. Main outcome measures were the Medication Communication Index (MCI), a 5-point index assessed by qualitative analysis of audio-recorded interactions (giving points for discussion of medication name, purpose, directions for use, duration of use, and side effects), and patient ratings of physician communication about new prescriptions. RESULTS Twenty-seven physicians prescribed 113 new medications to 82 of 256 patients. The mean MCI for medications prescribed by physicians in the intervention group was 3.95 (SD = 1.02), signif cantly higher than that for medications prescribed by control group physicians (2.86, SD = 1.23, P < 001). This effect held regardless of medication type (chronic vs nonchronic medication). Counseling about 3 of the 5 MCI components was signif cantly higher for medications prescribed by physicians in the intervention group, as were patients' ratings of new medication information transfer (P = 02). Independent of intervention or control groups, higher MCI scores were associated with better patient ratings about information about new prescriptions (P = 003). CONCLUSIONS A physician-targeted educational session improved the content of and enhanced patient ratings of physician communication about new medication prescriptions. Further work is required to assess whether improved communication stimulated by the intervention translates into better clinical outcomes.

AB - PURPOSE Physicians prescribing new medications often do not convey important medication-related information. This study tests an intervention to improve physician-patient communication about newly prescribed medications. METHODS We conducted a controlled clinical trial of patients in 3 primary care practices, combining data from patient surveys with audio-recorded physician-patient interactions. The intervention consisted of a 1-hour physician-targeted interactive educational session encouraging communication about 5 basic elements regarding a new prescription and a patient information handout listing the 5 basic elements. Main outcome measures were the Medication Communication Index (MCI), a 5-point index assessed by qualitative analysis of audio-recorded interactions (giving points for discussion of medication name, purpose, directions for use, duration of use, and side effects), and patient ratings of physician communication about new prescriptions. RESULTS Twenty-seven physicians prescribed 113 new medications to 82 of 256 patients. The mean MCI for medications prescribed by physicians in the intervention group was 3.95 (SD = 1.02), signif cantly higher than that for medications prescribed by control group physicians (2.86, SD = 1.23, P < 001). This effect held regardless of medication type (chronic vs nonchronic medication). Counseling about 3 of the 5 MCI components was signif cantly higher for medications prescribed by physicians in the intervention group, as were patients' ratings of new medication information transfer (P = 02). Independent of intervention or control groups, higher MCI scores were associated with better patient ratings about information about new prescriptions (P = 003). CONCLUSIONS A physician-targeted educational session improved the content of and enhanced patient ratings of physician communication about new medication prescriptions. Further work is required to assess whether improved communication stimulated by the intervention translates into better clinical outcomes.

KW - Communication

KW - Intervention studies

KW - Physician-patient relations

KW - Prescriptions

UR - http://www.scopus.com/inward/record.url?scp=84872357161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872357161&partnerID=8YFLogxK

U2 - 10.1370/afm.1417

DO - 10.1370/afm.1417

M3 - Article

C2 - 23319503

AN - SCOPUS:84872357161

VL - 11

SP - 28

EP - 36

JO - Annals of Family Medicine

JF - Annals of Family Medicine

SN - 1544-1709

IS - 1

ER -